2m 2m 2m 2m 2m 2m 2m
INDIVIOR PHARMA (INDV)
NASDAQ
$34.37-$0.12 (-0.35%)
Price as of Sep 11, 2026 7:42 PM EDT- $4.1BMarket Cap
- 48.60%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INDIVIOR PHARMA (INDV)
$34.37-$0.12 (-0.35%)
INDV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $34.49 | ||
Change | -$0.02 (-0.06%) | ||
Open | $34.49 | ||
High | $34.83 | ||
Low | $34.23 | ||
Previous Close | $34.51 | ||
Volume | 1,297,260 | ||
30-Day Average Volume | 1,895,525 | ||
1-Week Change | -1.29% | ||
1-Month Change | -10.25% | ||
1-Year Change | 48.60% | ||
3-Year Change | 52.81% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 118.0M | ||
Total Assets | $1.2B | ||
Market Cap | $4.1B | ||
Enterprise Value | $4.3B | ||
Period: QTR TTM FY | |||
Revenue | $343.0M | ||
Net Income | $122.0M | ||
Free Cash Flow | $222.0M | ||
EBIT | $160.0M | ||
EBITDA | $162.0M | ||
Net Working Capital | -$143.0M | ||
EPS | $0.98 | ||
Enterprise Value/EBITDA | 27 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -20 | ||
P/E | 35 | ||
PEG | 1 | ||
Price/Free Cash Flow | 18 | ||
Price/Operating Cash Flow | 18 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue